Holen Sie sich die Stockscreener-App
0.4942
1.40%
-0.007
Handel nachbörslich:
.49
-0.0042
-0.85%
Curis Inc Aktie (CRIS) Neueste Nachrichten
Curis (NASDAQ: CRIS) wins shareholder approval to double authorized common stock - Stock Titan
CRIS Should I Buy - Intellectia AI
Curis stock (US2312691006): Phase 1 data update lifts attention - AD HOC NEWS
CRIS News | CURIS INC (NASDAQ:CRIS) - ChartMill
Curis Inc Annual Shareholders Meeting Transcript - GuruFocus
CRIS: All five shareholder proposals, including director elections and share increase, were approved - TradingView
Curis to Host Webcast to Discuss Updated Emavusertib Clinical Da - GuruFocus
Curis Faces Nasdaq Delisting Determination, Plans Appeal Hearing - TipRanks
Curis stock (US2312691006): cancer pipeline update keeps investors cautious - AD HOC NEWS
Armistice Capital (NASDAQ: CRIS) reports 4.99% ownership of Curis - Stock Titan
JonesTrading Maintains Curis(CRIS.US) With Buy Rating, Maintains Target Price $5 - Moomoo
Thomas Satterfield holds 3.96M shares as Curis (CRIS) ownership amended - Stock Titan
Curis, Inc. (NASDAQ:CRIS) Q1 2026 Earnings Call Transcript - Insider Monkey
Curis Q1 2026 earnings preview - MSN
Curis Inc. Earnings Call Highlights Clinical Momentum - TipRanks
Curis Q1 2026 Deep Dive: EPS Misses by 331.0%, Revenue Down 100% - AlphaStreet
Curis, Inc. (CRIS) Reports Q1 2026 Loss and Updates on Clinical Trials - GuruFocus
CURIS INC 1Q 2026: Revenue $0 Net income ($24.2M), EPS ($1.25) — 10-Q Summary - TradingView
Curis (NASDAQ: CRIS) posts larger Q1 2026 loss and warns on going concern - Stock Titan
Q1 2026 Curis Inc Earnings Call Transcript - GuruFocus
Curis, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Curis anticipates TakeAim CLL initial 5-patient dosing by mid-2026 while projecting cash runway into second half of '27 - MSN
Curis Inc (CRIS) Q1 2026 Earnings Call Highlights: Progress in L - GuruFocus
Curis (CRIS) Expects Sufficient Funding to Support Operations Un - GuruFocus
Earnings call transcript: Curis Q1 2026 reveals widened net loss - Investing.com UK
Curis (CRIS) Reports Q1 Revenue Below Expectations - GuruFocus
Curis Q1 2026 Earnings Call Transcript - MarketBeat
Curis (CRIS) Q1 Miss: EPS -$1.25 vs -$0.40 est, Revenue $0 vs $1 - GuruFocus
Curis Provides First Quarter 2026 Business Update - GuruFocus
Curis Sees Cash Runway Into the 2H of 2027 >CRIS - Moomoo
Earnings call transcript: Curis Q1 2026 reveals widened net loss By Investing.com - Investing.com Nigeria
Curis Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Curis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Curis reports Q1 loss, expects CLL trial milestone by mid-2026 - Investing.com South Africa
Curis: Q1 Earnings Snapshot - kens5.com
Curis (NASDAQ: CRIS) posts larger Q1 2026 loss and flags funding needs - Stock Titan
TradingKey - TradingKey
Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 - Barchart
CRIS Q1'26 Earnings: EPS estimate is (0.33) USD - TradingView
Number of shareholders of Curis, Inc. – LSX:A3ETJD - TradingView
Curis Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - Quantisnow
Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024 - Quantisnow
Why Curis (CRIS) is trading below its true worth (-1.83%) 2026-05-05Wall Street Picks - newser.com
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):